Home › Funds › Citadel Advisors › ABUS
Citadel Advisors position in ABUS
ARBUTUS BIOPHARMA CORP · Health Care
Latest position (Q2 2026)404.70K sh
Reported value held$1.94M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.06M | $4.54M | New |
| Q4 2021 | 950.85K | $3.70M | Reduce |
| Q1 2022 | 826.98K | $2.46M | Reduce |
| Q2 2022 | 361.25K | $979.00K | Reduce |
| Q3 2022 | 457.96K | $874.00K | Add |
| Q4 2022 | 667.06K | $1.55M | Add |
| Q1 2023 | 398.54K | $1.21M | Reduce |
| Q2 2023 | 2.43M | $5.59M | Add |
| Q3 2023 | 2.14M | $4.34M | Reduce |
| Q4 2023 | 2.07M | $5.17M | Reduce |
| Q1 2024 | 2.20M | $5.66M | Add |
| Q2 2024 | 198.47K | $613.29K | Reduce |
| Q3 2024 | 697.74K | $2.69M | Add |
| Q4 2024 | 360.06K | $1.18M | Reduce |
| Q1 2025 | 214.91K | $750.05K | Reduce |
| Q2 2025 | 227.77K | $703.82K | Add |
| Q3 2025 | 277.09K | $1.26M | Add |
| Q4 2025 | 149.34K | $718.34K | Reduce |
| Q1 2026 | 785.24K | $3.53M | Add |
| Q2 2026 | 404.70K | $1.94M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABUS
- Morgan Stanley 17.70M sh · $84.95M · Q2 2026
- BlackRock Inc 13.77M sh · $66.08M · Q2 2026
- Vanguard Group 9.24M sh · $44.46M · Q4 2025
- Geode Capital Management 4.12M sh · $19.77M · Q2 2026
- Goldman Sachs Group 3.51M sh · $16.83M · Q2 2026
- Bank of America Corp 2.65M sh · $12.70M · Q2 2026
- Legal & General Investment Management America 2.47M sh · $11.84M · Q2 2026
- Charles Schwab Investment Management 1.43M sh · $6.87M · Q2 2026
- Northern Trust Corp 1.42M sh · $6.81M · Q2 2026
- Citigroup Inc 879.24K sh · $4.22M · Q2 2026
- Arrowstreet Capital 650.70K sh · $3.12M · Q2 2026
- Wellington Management Group 461.65K sh · $2.22M · Q2 2026